A new clustering method identifies multiple sclerosis-specific T-cell receptors

Ann Clin Transl Neurol. 2021 Jan;8(1):163-176. doi: 10.1002/acn3.51264. Epub 2021 Jan 5.

Abstract

Objective: To characterize T-cell receptors (TCRs) and identify target epitopes in multiple sclerosis (MS).

Methods: Peripheral blood mononuclear cells were obtained from 39 MS patients and 19 healthy controls (HCs). TCR repertoires for α/β/δ/γ chains, TCR diversity, and V/J usage were determined by next-generation sequencing. TCR β chain repertoires were compared with affectation status using a novel clustering method, Grouping of Lymphocyte Interactions by Paratope Hotspots (GLIPH). Cytomegalovirus (CMV)-IgG was measured in an additional 113 MS patients and 93 HCs. Regulatory T cells (Tregs) were measured by flow cytometry.

Results: TCR diversity for all four chains decreased with age. TCRα and TCRβ diversity was higher in MS patients (P = 0.0015 and 0.024, respectively), even after age correction. TRAJ56 and TRBV4-3 were more prevalent in MS patients than in HCs (pcorr = 0.027 and 0.040, respectively). GLIPH consolidated 208,674 TCR clones from MS patients into 1,294 clusters, among which two candidate clusters were identified. The TRBV4-3 cluster was shared by HLA-DRB1*04:05-positive patients (87.5%) and predicted to recognize CMV peptides (CMV-TCR). MS Severity Score (MSSS) was lower in patients with CMV-TCR than in those without (P = 0.037). CMV-IgG-positivity was associated with lower MSSS in HLA-DRB1*04:05 carriers (P = 0.0053). HLA-DRB1*04:05-positive individuals demonstrated higher CMV-IgG titers than HLA-DRB1*04:05-negative individuals (P = 0.017). CMV-IgG-positive patients had more Tregs than CMV-IgG-negative patients (P = 0.054).

Interpretation: High TCRα/TCRβ diversity, regardless of age, is characteristic of MS. Association of a CMV-recognizing TCR with mild disability indicates CMV's protective role in HLA-DRB1*04:05-positive MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cluster Analysis
  • Cytomegalovirus Infections / epidemiology
  • Cytomegalovirus Infections / immunology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis / immunology*
  • Receptors, Antigen, T-Cell / immunology*

Substances

  • Receptors, Antigen, T-Cell

Grants and funding

This work was funded by Japan Society for the Promotion of Science (JSPS) KAKENHI grants 16H02657, 16K09694, 18K07529, 19H01045, 19K07995, and 19K07997; Ministry of Health, Labour and Welfare, Japan grant .